UTI Statistics
Total Valuation
UTI has a market cap or net worth of $981.88 million. The enterprise value is $1.18 billion.
| Market Cap | 981.88M |
| Enterprise Value | 1.18B |
Important Dates
The next estimated earnings date is Tuesday, August 6, 2024, after market close.
| Earnings Date | Aug 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
UTI has 53.80 million shares outstanding. The number of shares has increased by 58.51% in one year.
| Shares Outstanding | 53.80M |
| Shares Change (YoY) | +58.51% |
| Shares Change (QoQ) | +46.29% |
| Owned by Insiders (%) | 2.70% |
| Owned by Institutions (%) | 87.44% |
| Float | 42.97M |
Valuation Ratios
The trailing PE ratio is 50.69 and the forward PE ratio is 22.16. UTI's PEG ratio is 1.75.
| PE Ratio | 50.69 |
| Forward PE | 22.16 |
| PS Ratio | 1.44 |
| Forward PS | 1.28 |
| PB Ratio | 4.22 |
| P/FCF Ratio | 28.87 |
| PEG Ratio | 1.75 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.83, with an EV/FCF ratio of 34.83.
| EV / Earnings | 74.74 |
| EV / Sales | 1.74 |
| EV / EBITDA | 12.83 |
| EV / EBIT | 27.28 |
| EV / FCF | 34.83 |
Financial Position
The company has a current ratio of 1.02, with a Debt / Equity ratio of 1.39.
| Current Ratio | 1.02 |
| Quick Ratio | 0.91 |
| Debt / Equity | 1.39 |
| Debt / EBITDA | 3.50 |
| Debt / FCF | 9.50 |
| Interest Coverage | 4.08 |
Financial Efficiency
Return on equity (ROE) is 7.00% and return on invested capital (ROIC) is 4.87%.
| Return on Equity (ROE) | 7.00% |
| Return on Assets (ROA) | 2.20% |
| Return on Capital (ROIC) | 4.87% |
| Revenue Per Employee | $227,485 |
| Profits Per Employee | $5,283 |
| Employee Count | 3,000 |
| Asset Turnover | 0.95 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, UTI has paid $8.40 million in taxes.
| Income Tax | 8.40M |
| Effective Tax Rate | 34.65% |
Stock Price Statistics
The stock price has increased by +154.53% in the last 52 weeks. The beta is 1.26, so UTI's price volatility has been higher than the market average.
| Beta (5Y) | 1.26 |
| 52-Week Price Change | +154.53% |
| 50-Day Moving Average | 15.47 |
| 200-Day Moving Average | 13.48 |
| Relative Strength Index (RSI) | 76.14 |
| Average Volume (20 Days) | 637,281 |
Short Selling Information
The latest short interest is 1.71 million, so 3.17% of the outstanding shares have been sold short.
| Short Interest | 1.71M |
| Short Previous Month | 1.29M |
| Short % of Shares Out | 3.17% |
| Short % of Float | 3.97% |
| Short Ratio (days to cover) | 2.68 |
Income Statement
In the last 12 months, UTI had revenue of $682.46 million and earned $15.85 million in profits. Earnings per share was $0.36.
| Revenue | 682.46M |
| Gross Profit | 311.03M |
| Operating Income | 36.43M |
| Pretax Income | 32.77M |
| Net Income | 15.85M |
| EBITDA | 92.32M |
| EBIT | 43.43M |
| Earnings Per Share (EPS) | $0.36 |
Balance Sheet
The company has $120.55 million in cash and $323.21 million in debt, giving a net cash position of -$202.66 million or -$3.77 per share.
| Cash & Cash Equivalents | 120.55M |
| Total Debt | 323.21M |
| Net Cash | -202.66M |
| Net Cash Per Share | -$3.77 |
| Equity (Book Value) | 232.61M |
| Book Value Per Share | 4.32 |
| Working Capital | 3.79M |
Cash Flow
In the last 12 months, operating cash flow was $61.81 million and capital expenditures -$27.80 million, giving a free cash flow of $34.01 million.
| Operating Cash Flow | 61.81M |
| Capital Expenditures | -27.80M |
| Free Cash Flow | 34.01M |
| FCF Per Share | $0.63 |
Margins
Gross margin is 45.57%, with operating and profit margins of 5.34% and 2.32%.
| Gross Margin | 45.57% |
| Operating Margin | 5.34% |
| Pretax Margin | 4.80% |
| Profit Margin | 2.32% |
| EBITDA Margin | 13.53% |
| EBIT Margin | 6.36% |
| FCF Margin | 4.98% |
Dividends & Yields
UTI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -58.51% |
| Shareholder Yield | -58.51% |
| Earnings Yield | 1.61% |
| FCF Yield | 3.46% |
Analyst Forecast
The average price target for UTI is $17.80, which is -2.47% lower than the current price. The consensus rating is "Strong Buy".
| Price Target | $17.80 |
| Price Target Difference | -2.47% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
UTI has an Altman Z-Score of 2.47 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.47 |
| Piotroski F-Score | 6 |